Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

N. Barabutis, Andrew V Schally

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Splice Variant 1 (SV-1) of growth hormone-releasing hormone (GHRH) receptor, found in a wide range of human cancers and established human cancer cell lines, is a functional receptor with ligand-dependent and independent activity. In the present study, we demonstrated by western blots the presence of the SV1 of GHRH receptor and the production of GHRH in MDA-MB-468, MDA-MB-435S and T47D human breast cancer cell lines, LNCaP prostate cancer cell line as well as in NCI H838 non-small cell lung carcinoma. We have also shown that GHRH produced in the conditioned media of these cell lines is biologically active. We then inhibited the intrinsic production of GHRH in these cancer cell lines using si-RNA, specially designed for human GHRH. The knocking down of the GHRH gene expression suppressed the proliferation of T47D, MDA-MB-435S, MDA-MB-468 breast cancer, LNCaP prostate cancer and NCI H838 non-SCLC cell lines in vitro. However, the replacement of the knocked down GHRH expression by exogenous GHRH (1-29)NH2 re-established the proliferation of the silenced cancer cell lines. Furthermore, the proliferation rate of untransfected cancer cell lines could be stimulated by GHRH (1-29)NH2 and inhibited by GHRH antagonists MZ-5-156, MZ-4-71 and JMR-132. These results extend previous findings on the critical function of GHRH in tumorigenesis and support the role of GHRH as a tumour growth factor.

Original languageEnglish
Pages (from-to)1790-1796
Number of pages7
JournalBritish Journal of Cancer
Volume98
Issue number11
DOIs
StatePublished - Jun 3 2008

Fingerprint

Growth Hormone-Releasing Hormone
Gene Expression
Cell Line
Neoplasms
Prostatic Neoplasms
Breast Neoplasms
Hormone Antagonists
Human Growth Hormone
Conditioned Culture Medium
Non-Small Cell Lung Carcinoma
Intercellular Signaling Peptides and Proteins
Carcinogenesis
Western Blotting
RNA

Keywords

  • Breast cancer
  • GHRH
  • Lung and prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. / Barabutis, N.; Schally, Andrew V.

In: British Journal of Cancer, Vol. 98, No. 11, 03.06.2008, p. 1790-1796.

Research output: Contribution to journalArticle

@article{b13d623f31e84bc8a158f487ff0c2add,
title = "Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines",
abstract = "Splice Variant 1 (SV-1) of growth hormone-releasing hormone (GHRH) receptor, found in a wide range of human cancers and established human cancer cell lines, is a functional receptor with ligand-dependent and independent activity. In the present study, we demonstrated by western blots the presence of the SV1 of GHRH receptor and the production of GHRH in MDA-MB-468, MDA-MB-435S and T47D human breast cancer cell lines, LNCaP prostate cancer cell line as well as in NCI H838 non-small cell lung carcinoma. We have also shown that GHRH produced in the conditioned media of these cell lines is biologically active. We then inhibited the intrinsic production of GHRH in these cancer cell lines using si-RNA, specially designed for human GHRH. The knocking down of the GHRH gene expression suppressed the proliferation of T47D, MDA-MB-435S, MDA-MB-468 breast cancer, LNCaP prostate cancer and NCI H838 non-SCLC cell lines in vitro. However, the replacement of the knocked down GHRH expression by exogenous GHRH (1-29)NH2 re-established the proliferation of the silenced cancer cell lines. Furthermore, the proliferation rate of untransfected cancer cell lines could be stimulated by GHRH (1-29)NH2 and inhibited by GHRH antagonists MZ-5-156, MZ-4-71 and JMR-132. These results extend previous findings on the critical function of GHRH in tumorigenesis and support the role of GHRH as a tumour growth factor.",
keywords = "Breast cancer, GHRH, Lung and prostate cancer",
author = "N. Barabutis and Schally, {Andrew V}",
year = "2008",
month = "6",
day = "3",
doi = "10.1038/sj.bjc.6604386",
language = "English",
volume = "98",
pages = "1790--1796",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

AU - Barabutis, N.

AU - Schally, Andrew V

PY - 2008/6/3

Y1 - 2008/6/3

N2 - Splice Variant 1 (SV-1) of growth hormone-releasing hormone (GHRH) receptor, found in a wide range of human cancers and established human cancer cell lines, is a functional receptor with ligand-dependent and independent activity. In the present study, we demonstrated by western blots the presence of the SV1 of GHRH receptor and the production of GHRH in MDA-MB-468, MDA-MB-435S and T47D human breast cancer cell lines, LNCaP prostate cancer cell line as well as in NCI H838 non-small cell lung carcinoma. We have also shown that GHRH produced in the conditioned media of these cell lines is biologically active. We then inhibited the intrinsic production of GHRH in these cancer cell lines using si-RNA, specially designed for human GHRH. The knocking down of the GHRH gene expression suppressed the proliferation of T47D, MDA-MB-435S, MDA-MB-468 breast cancer, LNCaP prostate cancer and NCI H838 non-SCLC cell lines in vitro. However, the replacement of the knocked down GHRH expression by exogenous GHRH (1-29)NH2 re-established the proliferation of the silenced cancer cell lines. Furthermore, the proliferation rate of untransfected cancer cell lines could be stimulated by GHRH (1-29)NH2 and inhibited by GHRH antagonists MZ-5-156, MZ-4-71 and JMR-132. These results extend previous findings on the critical function of GHRH in tumorigenesis and support the role of GHRH as a tumour growth factor.

AB - Splice Variant 1 (SV-1) of growth hormone-releasing hormone (GHRH) receptor, found in a wide range of human cancers and established human cancer cell lines, is a functional receptor with ligand-dependent and independent activity. In the present study, we demonstrated by western blots the presence of the SV1 of GHRH receptor and the production of GHRH in MDA-MB-468, MDA-MB-435S and T47D human breast cancer cell lines, LNCaP prostate cancer cell line as well as in NCI H838 non-small cell lung carcinoma. We have also shown that GHRH produced in the conditioned media of these cell lines is biologically active. We then inhibited the intrinsic production of GHRH in these cancer cell lines using si-RNA, specially designed for human GHRH. The knocking down of the GHRH gene expression suppressed the proliferation of T47D, MDA-MB-435S, MDA-MB-468 breast cancer, LNCaP prostate cancer and NCI H838 non-SCLC cell lines in vitro. However, the replacement of the knocked down GHRH expression by exogenous GHRH (1-29)NH2 re-established the proliferation of the silenced cancer cell lines. Furthermore, the proliferation rate of untransfected cancer cell lines could be stimulated by GHRH (1-29)NH2 and inhibited by GHRH antagonists MZ-5-156, MZ-4-71 and JMR-132. These results extend previous findings on the critical function of GHRH in tumorigenesis and support the role of GHRH as a tumour growth factor.

KW - Breast cancer

KW - GHRH

KW - Lung and prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=44349126257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349126257&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6604386

DO - 10.1038/sj.bjc.6604386

M3 - Article

C2 - 18506184

AN - SCOPUS:44349126257

VL - 98

SP - 1790

EP - 1796

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 11

ER -